Skip to content

Research at St Andrews

John Keats, medicine, and poetry

Research output: Contribution to journalLetter

Standard

John Keats, medicine, and poetry. / Roe, Nicholas.

In: Lancet, Vol. 397, No. 10278, 13.03.2021, p. 962-963.

Research output: Contribution to journalLetter

Harvard

Roe, N 2021, 'John Keats, medicine, and poetry', Lancet, vol. 397, no. 10278, pp. 962-963. https://doi.org/10.1016/S0140-6736(21)00450-5

APA

Roe, N. (2021). John Keats, medicine, and poetry. Lancet, 397(10278), 962-963. https://doi.org/10.1016/S0140-6736(21)00450-5

Vancouver

Roe N. John Keats, medicine, and poetry. Lancet. 2021 Mar 13;397(10278):962-963. https://doi.org/10.1016/S0140-6736(21)00450-5

Author

Roe, Nicholas. / John Keats, medicine, and poetry. In: Lancet. 2021 ; Vol. 397, No. 10278. pp. 962-963.

Bibtex - Download

@article{99edce92402740f19358e7f40c474668,
title = "John Keats, medicine, and poetry",
abstract = "“I find that I cannot exist without poetry”, John Keats (1795–1821) proclaimed—”eternal poetry” was the essence of life itself. Yet poetry had not always seemed such a singular, compelling cause. For 7 years from 1810 Keats had studied medicine, as he prepared for a career as a surgeon. It was only gradually that he came to see poetry as his true calling, a life-enhancing alternative to the limited resources of contemporary medicine.",
author = "Nicholas Roe",
year = "2021",
month = mar,
day = "13",
doi = "10.1016/S0140-6736(21)00450-5",
language = "English",
volume = "397",
pages = "962--963",
journal = "Lancet",
issn = "0037-9808",
publisher = "Elsevier Inc.",
number = "10278",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - John Keats, medicine, and poetry

AU - Roe, Nicholas

PY - 2021/3/13

Y1 - 2021/3/13

N2 - “I find that I cannot exist without poetry”, John Keats (1795–1821) proclaimed—”eternal poetry” was the essence of life itself. Yet poetry had not always seemed such a singular, compelling cause. For 7 years from 1810 Keats had studied medicine, as he prepared for a career as a surgeon. It was only gradually that he came to see poetry as his true calling, a life-enhancing alternative to the limited resources of contemporary medicine.

AB - “I find that I cannot exist without poetry”, John Keats (1795–1821) proclaimed—”eternal poetry” was the essence of life itself. Yet poetry had not always seemed such a singular, compelling cause. For 7 years from 1810 Keats had studied medicine, as he prepared for a career as a surgeon. It was only gradually that he came to see poetry as his true calling, a life-enhancing alternative to the limited resources of contemporary medicine.

U2 - 10.1016/S0140-6736(21)00450-5

DO - 10.1016/S0140-6736(21)00450-5

M3 - Letter

C2 - 33631129

VL - 397

SP - 962

EP - 963

JO - Lancet

JF - Lancet

SN - 0037-9808

IS - 10278

ER -

Related by author

  1. Wordsworth and Coleridge: the radical years

    Roe, N., 29 Nov 2018, 2nd ed. Oxford : Oxford University Press. 323 p.

    Research output: Book/ReportBook

  2. John Keats at Winchester

    Roe, N., 21 Sep 2018, Keats’s Places. Turley, R. M. (ed.). Palgrave Macmillan, p. 225-243

    Research output: Chapter in Book/Report/Conference proceedingChapter

  3. The birth of romance

    Roe, N. H., 1 Dec 2017, Literary Review, 460, p. 33-34 2 p.

    Research output: Contribution to specialist publicationBook/Film/Article review

  4. John Keats and the medical imagination

    Roe, N. H. (ed.), Dec 2017, Cham, Switzerland: Palgrave Macmillan. 262 p. (Palgrave studies in literature, science and medicine)

    Research output: Book/ReportBook

  5. Charles Armitage Brown, John Keats and Plymouth

    Roe, N., Sep 2017, In: Keats-Shelley Review. 31, 2, p. 120-135 16 p.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Mass infection is not an option: we must do more to protect our young

    Gurdasani, D., Drury, J., Greenhalgh, T., Griffin, S., Haque, Z., Hyde, Z., Katzourakis, A., McKee, M., Michie, S., Pagel, C., Reicher, S., Roberts, A., West, R., Yates, C. & Ziauddeen, H., 7 Jul 2021, (E-pub ahead of print) In: The Lancet. In Press

    Research output: Contribution to journalComment/debate

  2. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    RECOVERY Collaborative Group, 29 May 2021, In: Lancet. 397, 10289, p. 2049-2059 11 p.

    Research output: Contribution to journalArticlepeer-review

  3. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

    SIREN Study Group, 8 May 2021, In: Lancet. 397, 10286, p. 1725-1735 11 p.

    Research output: Contribution to journalArticlepeer-review

  4. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

    Vasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., Bedston, S., Beggs, J., Bradley, D., Chuter, A., de Lusignan, S., Docherty, A. B., Ford, D., Hobbs, FD. R., Joy, M., Katikireddi, S. V., Marple, J., McCowan, C., McGagh, D., McMenamin, J. & 12 others, Moore, E., Murray, J. LK., Pan, J., Ritchie, L., Shah, S. A., Stock, S., Torabi, F., Tsang, R. SM., Wood, R., Woolhouse, M., Robertson, C. & Sheikh, A., 1 May 2021, In: The Lancet. 397, 10285, p. 1646-1657

    Research output: Contribution to journalArticlepeer-review

  5. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    RECOVERY Collaborative Group, 1 May 2021, In: Lancet. 397, 10285, p. 1637-1645 9 p.

    Research output: Contribution to journalArticlepeer-review

ID: 274691385

Top